1. Is there a role for postoperative treatment in patients with stage Ib2–IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study
   F. Landoni et al, 2014, Gynecologic Oncology CrossRef
2. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up
   Shinn-Yn Lin et al, 2015, International Journal of Radiation Oncology*Biology*Physics CrossRef
3. Association between expression of MMP‐7 and MMP‐9 and pelvic lymph node and para‐aortic lymph node metastasis in early cervical cancer
   Hui Guo et al, 2018, Journal of Obstetrics and Gynaecology Research CrossRef
4. Comparison of efficacy and safety between late-course and simultaneous integrated dose-increasing intensity-modulated radiation therapy for cervical cancer complicated with pelvic lymph node metastasis
   Yi Cheng et al, 2019, Oncology and Translational Medicine CrossRef
5. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy
   Ning Wu et al, 2021, Cancer Control CrossRef
6. Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer
   V. S. Haritha et al, 2022, Indian Journal of Gynecologic Oncology CrossRef
7. Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer
   Kyungmi Yang et al, 2017, Radiation Oncology Journal CrossRef
8. Neoadjuvant Chemotherapy in Cervical Cancer: A Review Article
   Elham Shirali et al, 2018, Journal of Obstetrics, Gynecology and Cancer Research CrossRef
9. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
   Fengying Qin et al, 2022, Technology in Cancer Research & Treatment CrossRef
10. Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01
    Jong Hoon Lee et al, 2017, Gynecologic Oncology CrossRef
11. Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers
    Elodie Chantalat et al, 2015, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef
12. Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines
    Ji Geun Yoo et al, 2024, Journal of Gynecologic Oncology CrossRef
13. Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2–IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: An Italian multicenter retrospective study (CTF Study)
    A. Gadducci et al, 2013, Gynecologic Oncology CrossRef
14. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
    Haonan Liu et al, 2022, Frontiers in Oncology CrossRef
15. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
    Nanda Horeweg et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
16. Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?
    Virginia Benito et al, 2017, Journal of Minimally Invasive Gynecology CrossRef
17. Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis
    Yidi Yuan et al, 2022, International Journal of Gynecologic Cancer CrossRef
18. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study
    Gong-yi Zhang et al, 2022, BMC Cancer CrossRef
19. Nodal metastasis in gynecologic malignancies: Update on imaging and management
    Subramaniyan Ramanathan et al, 2020, Clinical Imaging CrossRef
20. Adjuvant Systemic Therapy after Chemoradiation and Brachytherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis
    Nanda Horeweg et al, 2021, Cancers CrossRef
21. Rational design, synthesis, and 2D-QSAR study of anti-oncological alkaloids against hepatoma and cervical carcinoma
    Adel S. Girgis et al, 2015, RSC Advances CrossRef
22. Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables
    Angiolo Gadducci et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
23. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone
    Guangchao Wei et al, 2022, Magnetic Resonance Imaging CrossRef
24. Toxicity Profile of Double-agent Adjuvant Chemotherapy after Concurrent Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer: Comparison with Standard Chemoradiation Protocol
    Tejas Pandya et al, 2019, Indian Journal of Medical and Paediatric Oncology CrossRef
25. Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis
    Xiao Ma et al, 2023, Critical Reviews in Oncology/Hematology CrossRef